Tissue microarrays: What will they bring to molecular and anatomic pathology?

被引:114
作者
Moch, H
Kononen, J
Kallioniemi, OP
Sauter, G
机构
[1] Univ Basel, Inst Pathol, CH-4003 Basel, Switzerland
[2] NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA
关键词
tissue chips; tissue microarray; quality control; high throughput analysis; immunohistochemistry; molecular biology;
D O I
10.1097/00125480-200101000-00002
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The analysis of a large number of tumor tissues with conventional techniques of molecular pathology is tedious and slow. The authors recently developed the tissue microarray technology that makes it possible to sample up to 1000 tumors on one grass slide, which then can be analyzed by fluorescence in situ hybridization, RNA in situ hybridization, or immunohistochemistry. The tissue microarray technology has the potential to significantly accelerate molecular studies that seek associations between molecular changes and clinicopathologic features of the cancer. Examples of potential applications for tissue microarrays include testing and optimization of probes and antibodies, the organization of large tissue repositories, and the facilitation of multicenter studies. Further, tissue microarrays can be used for educational purposes as well as to improve quality control and standardization of staining methods and interpretation. Tissue microarrays have become one of the most promising tools for the molecular and anatomic pathologist and will have many applications in cancer research, as well as in other fields of pathology. This review article gives an overview of current applications of tissue microarrays as well as possible future development of the technology.
引用
收藏
页码:14 / 20
页数:7
相关论文
共 13 条
[1]  
BATTIFORA H, 1986, LAB INVEST, V55, P244
[2]   Hormone therapy failure in human prostate cancer:: Analysis by complementary DNA and issue microarrays [J].
Bubendorf, L ;
Kolmer, M ;
Kononen, J ;
Koivisto, P ;
Mousses, S ;
Chen, YD ;
Mahlamäki, E ;
Schraml, P ;
Moch, H ;
Willi, N ;
Elkahloun, AG ;
Pretlow, TG ;
Gasser, TC ;
Mihatsch, MJ ;
Sauter, G ;
Kallioniemi, OP .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (20) :1758-1764
[3]  
Bubendorf L, 1999, CANCER RES, V59, P803
[4]  
BUBENDORF L, 1999, 49 ANN M
[5]  
DeRisi J, 1996, NAT GENET, V14, P457
[6]   Tissue microarrays for high-throughput molecular profiling of tumor specimens [J].
Kononen, J ;
Bubendorf, L ;
Kallioniemi, A ;
Bärlund, M ;
Schraml, P ;
Leighton, S ;
Torhorst, J ;
Mihatsch, MJ ;
Sauter, G ;
Kallioniemi, OP .
NATURE MEDICINE, 1998, 4 (07) :844-847
[7]   High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma [J].
Moch, H ;
Schraml, P ;
Bubendorf, L ;
Mirlacher, M ;
Kononen, J ;
Gasser, T ;
Mihatsch, MJ ;
Kallioniemi, OP ;
Sauter, G .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (04) :981-986
[8]   Neuroendocrine expression in metastatic prostate cancer: Evaluation of high throughput tissue microarrays to detect heterogeneous protein expression [J].
Mucci, NR ;
Akdas, G ;
Manely, S ;
Rubin, MA .
HUMAN PATHOLOGY, 2000, 31 (04) :406-414
[9]  
Peters R, 1998, SCIENCE, V281, P1163
[10]   High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer [J].
Richter, J ;
Wagner, U ;
Kononen, J ;
Fijan, A ;
Bruderer, J ;
Schmid, U ;
Ackermann, D ;
Maurer, R ;
Alund, G ;
Knönagel, H ;
Rist, M ;
Wilber, K ;
Anabitarte, R ;
Hering, F ;
Hardmeier, T ;
Schönenberger, A ;
Flury, R ;
Jäger, P ;
Fehr, JL ;
Schraml, P ;
Moch, H ;
Mihatsch, MJ ;
Gasser, T ;
Kallioniemi, OP ;
Sauter, G .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (03) :787-794